Pisani RJ, Colby TV, Williams DE. Malignant mesothelioma of the pleura. Mayo Clin Proc 63:1234- 
1244, 1988 . 
Ram Z, Culver KW, Walbridge, Blaese, Oldfield EH. In situ retroviral-mediated gene transfer for 
the treatment of brain tumors in rats. Cancer Research, 53: 83-88, 1993. 
Ram, Z, Walbridge, S, Oshiro, EM, Viola, JJ, Chiang, Y, Mueller, SN, Blaese, RM, Oldfield, EH. 
Intrathecal gene therapy for malignant leptomeningeal neoplasia. Cancer Research, 54:2141- 
2145, 1994. 
Rusch, VW. Pleurectomy/decortication and adjuvant therapy for malignant mesothelioma. Chest, 
1 03:382S-384S, 1993. 
Sentes R. The asbestos albatros. Policy Options 3-8, 1989. 
Setoguchi, Y, Jaffe, HA, Chum C-S, Crystal, RG. Intraperitoneal in vivo gene therapy to deliver al- 
antitrypsin to the systemic circulation. Am J Respir Cell Mol Biol, 10:369-377, 1994. 
Simon RH, Engelhardt JF, Yang Y, Zepeda M, Pendleton SW, Grossman M and Wilson JM: 
Adenovirus-Mediated Transfer of the CFTR Gene to Lung of Non-human Primates: Toxicity 
Study. Human Gene Therapy 4:771-780, 1993. 
Smythe WR, Kaiser LR, Amin KM, Pilewski JM, Eck S, Wilson JM, Albelda SM. Successful 
adenovirus-mediated gene transfer in an in vivo model of human malignant mesothelioma Ann. 
Thor.Surg. (in press-June),1 994a. 
Smythe, W.R., Hwang, H.C, Amin, K.M., Eck, S.L., Wilson, J.M., Kaiser, L.R., Albelda, S.M. 
Successful treatment of experimental human mesothelioma using adenovirus transfer of the 
herpes simplex-thymidine kinase gene, (submitted), 1994c. 
Smythe, WR, Hwang, HC, Amin, KM, Eck, SJ, Wilson, JM, Kaiser, LR, Albelda, SM. Recombinant 
adenovirus transfer of the HSV-thymidine kinase gene to thoracic neoplasms: An effective in 
vitro drug sensitization system. Cancer Research 54: 2055-2059, 1994b. 
Sugarbaker DJ, et al. Extrapleural pneumonectomy, chemotherapy and radiotherapy in thetreatment 
of diffuse malignant plerual mesothelioma. J Thorac Cardiovasc Surg102:10-15, 1991. 
Wilson, JM. Gene therapy of cystic fibrosis lung disease using El -deleted adenoviruses: a Phase 1 
trial. Human Gene Therapy, 1994, 5:501-519. 
Yang Y, Nunes F, Berencsi K, Furth E, Gonczol E, Wilson JM. Cellular immunity to viral antigens 
limits El -deleted adenoviruses for gene therapy. PNAS, USA, 91,4407-4411,1994. 
Recombinant DNA Research, Volume 20 
[413] 
